Search

Your search keyword '"Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Virologie"' showing total 21 results

Search Constraints

Start Over You searched for: Author "Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Virologie" Remove constraint Author: "Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Virologie" Topic 3. good health Remove constraint Topic: 3. good health
21 results on '"Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Virologie"'

Search Results

1. Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients

2. Sofosbuvir-based antiviral therapy in hepatitis C virus patients with severe renal failure

3. Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study

4. Predictive Factors for Hepatocellular Carcinoma in Chronic Hepatitis B Using Structural Equation Modeling: A Prospective Cohort Study

5. Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care

6. Tight junction proteins in gastrointestinal and liver disease

7. Direct-acting antiviral agent–based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study

8. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment a prospective cohort study

9. Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity

10. Safety of sofosbuvir-based regimens after liver transplantation longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study

11. Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human Hepatocytes

12. A Global Interactome Map of the Dengue Virus NS1 Identifies Virus Restriction and Dependency Host Factors

13. A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses

14. Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease

15. Functional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes using monoclonal antibodies

16. A bile acid transporter as a candidate receptor for hepatitis B and D virus entry

17. Hepatitis C Virus Envelope Glycoprotein Signatures Are Associated With Treatment Failure and Modulation of Viral Entry and Neutralization

18. A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission

19. Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study

20. Hepatitis B Virus Core Variants, Liver Fibrosis, and Hepatocellular Carcinoma

21. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis

Catalog

Books, media, physical & digital resources